AI assistant
HARVARD BIOSCIENCE INC — Director's Dealing 2022
Jan 3, 2022
34975_dirs_2022-01-03_69acad89-ebf1-47a5-8890-53830a43bda2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2021-12-29
Reporting Person: Rossi Michael A. (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-12-29 | Common Stock | F | 3163 | $7.27 | Disposed | 227859 | Direct |
| 2021-12-29 | Common Stock | F | 3763 | $7.27 | Disposed | 224096 | Direct |
Footnotes
F1: The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with a performance restricted stock unit award previously granted to the Reporting Person that vested in part on December 29, 2021.
F2: Includes (a) 43,092 remaining restricted stock units that will vest on June 11, 2022 and 2023, (b) 25,641 restricted stock units that will vest in two equal installments on December 29, 2022 and 2023, (c) 36,876 restricted stock units with performance based vesting conditions, (d) 23,878 remaining restricted stock units that will vest on July 18, 2022, (e) 21,545 remaining restricted stock units that will vest on December 29, 2022 and 2023, and (f) 76,827 shares of common stock beneficially owned by the Reporting Person.
F3: The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with a performance restricted stock unit award previously granted to the Reporting Person that vested in part on December 29, 2021.
F4: Includes (a) the shares and awards described in footnote (2) above, less (b) the disposition of shares reported in footnote (3) above.